Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

You are here: Home » News & Analysis

News & Analysis


China biotech company and industry news and analysis...

Recent Articles

  China Ebola Vaccine Passes Phase I Test
  CASI Starts China Arm of Phase II Breast Cancer Trial
  Sinophi to Distribute Proton Beam Machines in China
  Critical Diagnostics Gains China Approval for Heart Risk Assay
  CardioKinetix Announces Positive Data from Heart Failure Device Trial
  UniTao Pharma Puts Planned US Facility on Hold
  ZAI Lab In-licenses Potential Liver Cancer Drug from BMS
  Innovent and Lilly Form Major Cancer Biologics Collaboration
  Zhejiang ChiMin Pharma Stages $47 Million IPO in Shanghai
  Hanmi Pharma and Lilly Sign $690 Million Deal for Autoimmune Drug


ChinaBio® Events
Shanghai, China
April 15-16, 2015

>> More events...

Partner Events

China Healthcare Investment Conference
March 31 – April 2, 2015
Shanghai, China

Asia Biotech Invest 2015
May19-21, 2015
Hong Kong, China
>> More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors